Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seonghae Yoon

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|February 4, 2021
Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosisEun Sun Kim, Byoung Soo Kwon, Jong Sun Park, et al.
Scientific Reports|November 14, 2019
Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionDa Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Scientific Reports|August 10, 2018
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionDa Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2017
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy VolunteersSoo Youn Jun, In Jin Jang, Seonghae Yoon, et al.
Journal of Geriatric Oncology|March 1, 2021
A single-arm feasibility study of gradual dose de-escalation of antiemetic dexamethasone for older patients receiving chemotherapyKoung Jin Suh, Seonghae Yoon, Jin Won Kim, et al.
Scientific Reports|September 30, 2024
Impact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumoniaJiwon Ryu, Nak-Hyun Kim, Jung Hun Ohn, et al.
BMC Medical Informatics and Decision Making|March 1, 2026
Transforming unstructured breast cancer pathology reports into the Observational Medical Outcomes Partnership Common Data ModelBorham Kim, Wongeun Song, Eunsil Yoon, et al.
The Oncologist|June 27, 2026
Phase IB/II study of alpelisib combined with paclitaxel in patients with PIK3CA-altered metastatic or recurrent gastric cancerJi-Won Kim, Seonghae Yoon, Min-Hee Ryu, et al.
Journal of Korean Medical Science|April 11, 2023
Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM ResultsByungwook Kim, Sejung Hwang, Eunjeong Heo, et al.
Pharmacology Research & Perspectives|March 13, 2020
Phase I and pharmacokinetic study of the vascular-disrupting agent CKD-516 (NOV120401) in patients with refractory solid tumorsHark Kyun Kim, Jeong Won Kang, Young-Whan Park, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|February 4, 2021
Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosisEun Sun Kim, Byoung Soo Kwon, Jong Sun Park, et al.
Scientific Reports|November 14, 2019
Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionDa Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Scientific Reports|August 10, 2018
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionDa Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2017
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy VolunteersSoo Youn Jun, In Jin Jang, Seonghae Yoon, et al.
Journal of Geriatric Oncology|March 1, 2021
A single-arm feasibility study of gradual dose de-escalation of antiemetic dexamethasone for older patients receiving chemotherapyKoung Jin Suh, Seonghae Yoon, Jin Won Kim, et al.
Scientific Reports|September 30, 2024
Impact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumoniaJiwon Ryu, Nak-Hyun Kim, Jung Hun Ohn, et al.
BMC Medical Informatics and Decision Making|March 1, 2026
Transforming unstructured breast cancer pathology reports into the Observational Medical Outcomes Partnership Common Data ModelBorham Kim, Wongeun Song, Eunsil Yoon, et al.
The Oncologist|June 27, 2026
Phase IB/II study of alpelisib combined with paclitaxel in patients with PIK3CA-altered metastatic or recurrent gastric cancerJi-Won Kim, Seonghae Yoon, Min-Hee Ryu, et al.
Journal of Korean Medical Science|April 11, 2023
Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM ResultsByungwook Kim, Sejung Hwang, Eunjeong Heo, et al.
Pharmacology Research & Perspectives|March 13, 2020
Phase I and pharmacokinetic study of the vascular-disrupting agent CKD-516 (NOV120401) in patients with refractory solid tumorsHark Kyun Kim, Jeong Won Kang, Young-Whan Park, et al.
Pageof 5